Keywords: glaxo, wellcome, reveals, new, moves, zantac, litigation

Glaxo Wellcome Reveals New Moves In Zantac Litigation

Article | 17 July 1995

Print This

Glaxo Wellcome has announced that it has instituted patent infringement proceedings against Boehringer Ingelheim in the US District Court in ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in